During International Pharmaceutical Expo USA (Interphex) to be held in New York from April 26-28, Telstar will promote the latest generation of Sterility Test Isolators integrated with the innovative ionized Hydrogen Peroxide (ionHP) bio-decontamination system, which has proven to dramatically decrease cycle times.

The ionHP system is the latest leading-edge bio-decontamination technology for aseptic systems, developed to resolve some of the traditional difficulties associated with H2O2 bio-decontamination processes. Unlike conventional systems, the ionHP technology developed by Telstar increases the efficacy of the bio-decontamination process and reduces degradation of construction materials while using a very low concentration of H2O2. Reduced bio-decontamination cycle times are possible since the process efficiency is not affected by temperature and humidity and therefore there is no need to pre-condition the chamber prior to H2O2 injection.

The ionHP bio-decontamination system incorporated in the new Telstar Pura will be promoted at Interphex. Telstar Pura is a range of two, three and four glove Sterility Test Isolators, with the option of a transfer chamber for batch or continuous sterility testing. It is designed to avoid the risk of false results and to protect the product from both the process and externally generated factors that would compromise its quality. The Telstar Pura range is suitable for performing both Direct Inoculation and Filter Membrane sterility tests.

During Interphex Telstar will also be promoting its latest innovations in the field of process equipment developed with lyophilization, sterilization and water & pure steam technologies, specifically directed at the pharmaceutical and biotechnological industry.

In the lyophilization field, Telstar will promote the new generation of vial loading and unloading systems which can be integrated with freeze dryers and offer greater robustness, efficiency, reliability and accuracy in the vial transport and transfer process. In addition the units offer to easier cleaning and simplified maintenance. The new range of this equipment features improvements in the transport conveyor transition modules and in vial alignment systems which offer increased security of vial transport in loading and unloading processes, resulting in elimination of breakage and significant reduction in rejects. The improvements include new vial descrambling modules that are suitable for unloading processes up to 400 vials per minute with a typical rejection rate of 0.01 per cent. Telstar has also introduced an ultra-compact loading mechanism that results in a 40 per cent reduction of space required in the clean room.

An innovative isolation valve –the Telstar Cartridge Mushroom Valve- designed to connect the drying chamber and condenser of freeze dryers with less complexity and easier maintenance to enhance process safety, will also be promoted at Interphex together with the latest generation of LyoBeta, the Pilot-scale Freeze Dryer designed for experimentation and research and formulation to develop recipes for pharmaceutical freeze drying processes, prior to the full scale production.

Telstar will also promote the new compact steam sterilizing autoclave with GMP design developed to minimise footprint while maximising maintenance access. The equipment includes hinged front-facing access panels which open completely to provide full access to the technical area of the equipment. Finally, in the field of water & pure steam generation technologies, the company will offer the latest purified water systems designed to generate pharmaceutical purified water which allows chemical sanitization of the entire unit.

Telstar, part of the azbil Group, is a company that develops high-technology solutions of engineering, construction, equipment and services for the life sciences market. At the same time, Telstar is considered the only international manufacturer able to offer integrated process solutions for the biopharmaceutical industry with in-house sterilization, freeze drying, isolation and clean air technologies. Telstar invests 3 per cent of its turnover in research, development and innovation of its technologies and equipment.